In one paragraphArticle in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors.
Kenneth R DurbinProteomics Center of Excellence, Evanston, IL, USA.
Michael A R HollasProteomics Center of Excellence, Evanston, IL, USA.
G Larry MaxwellDepartment of Gynecologic Surgery and Obstetrics and the Gynecologic Cancer Center of Excellence, John P. Murtha Cancer Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Thomas P ConradsDepartment of Gynecologic Surgery and Obstetrics and the Gynecologic Cancer Center of Excellence, John P. Murtha Cancer Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-4742-3281 Ryan T FellersProteomics Center of Excellence, Evanston, IL, USA.
Rafael D MelaniDepartments of Molecular Biosciences, Chemistry, and the Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.
Neil L KelleherDepartments of Molecular Biosciences, Chemistry, and the Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. n-kelleher@northwestern.edu.ORCID http://orcid.org/0000-0002-8815-3372 Funding
Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9MThe UIUC Neuroproteomics Center on Cell-Cell SignalingP30DA018310 · NIDA · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Elena V Romanova · 2004 to 2026
$24.9MTR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6MRenewable and Specific Affinity Reagents for Mapping Proteoforms in Human TissuesUH3CA246635 · NCI · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2019 to 2021
$1.4MSingle Cell Proteoform Profiling using Top-Down Mass SpectrometryK99AI183290 · NIAID · NORTHWESTERN UNIVERSITY · PI SU, PEI · 2024 to 2025
$249kAlzheimer's Disease Characterization via a Novel Native Mass Spectrometry PlatformF31AG069456 · NIA · NORTHWESTERN UNIVERSITY · PI MCGEE, JOHN PHILIP · 2020 to 2021
$84kNCI NIH HHS P30 CA060553NCI NIH HHS UH3 CA246635NIAID NIH HHS K99 AI183290NIA NIH HHS F31 AG069456NIDA NIH HHS P30 DA018310NIGMS NIH HHS P41 GM108569
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID38040721
PMCPMC10692193
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390